Trimi vs Embody
Both clinics sit in our top 10, so this page exists for readers already comparing them here. It is not written for search and is not submitted for indexing. Every figure below is read from the clinic's own page, with the date.
26 of the 51 clinics we rank are an affiliate partner. Scores come only from our published methodology. At equal displayed scores, active affiliate partners are listed first. What it changes is which clinic a promoted button points at, and every such link carries a PICK badge in the table so you can see it before you click.
Says outright that its headline is a monthly equivalent of annual billing, and prints the no-commitment rate beside it instead of leaving you to find it at checkout.
from $99/mo on a 12-month prepaid plan
Verified 2026-09-21
| Trimi | Embody | |
|---|---|---|
| Price | from $99/mo on a 12-month prepaid planTheir page, read 2026-09-21 | from $79/mo for a one-month supply (sale price)Their page, read 2026-09-14 |
| Price shape | one-ongoing-rate | not-verified |
| What the price doesn’t say | $99/mo is a monthly equivalent of $1,188 billed upfront on a 12-month commitment. Not a month you can pay and stop. With no commitment it is $175/mo. Tirzepatide is $125/mo on the same 12-month basis, or $235/mo with no commitment. | This price depends on which link you arrive through, so treat no single number as the price. Our affiliate link resolves to a countdown-gated $69/mo intro that steps up after the first month; Embody's own public homepage shows $79, and a direct visit has shown $99. |
| What it covers | 12 months of compounded semaglutide, supplies, licensed provider care, ongoing support and free overnight shippingTheir page, read 2026-09-21 | Not published. The page does not say what the figure covers.Their page, read 2026-09-14 |
| Billed on top | Not recorded. We have not found a statement either way.Their page, read 2026-09-21 | Not recorded. We have not found a statement either way.Their page, read 2026-09-14 |
| Commitment | Committed term. The rate applies on a 12-month prepaid plan. Billed up front on that term. What happens after the first period: Trimi states on the page that the figures shown are monthly equivalents of annual billing, and prints the no-commitment rate ($175/mo semaglutide, $235/mo tirzepatide) next to them.Their page, read 2026-09-21 | Committed term. The rate applies for a one-month supply (sale price). What happens after the first period: The ongoing cost is the 12-month tier at $149/mo; the cheap headline is the first-month figure.Their page, read 2026-09-14 |
| Routes | compounded semaglutide, compounded tirzepatide | compounded semaglutide, compounded tirzepatide, oral (gum) |
| Score | 7.9 | 7.2 |
What is on the record
Documented findings, each with its source and date on the clinic’s review page. An FDA warning letter is an allegation by the agency, not a court ruling.
Trimi
Nothing documented in what we check.
Embody
- Two storefronts, one companyEmbody and SnagRx are the same company
- Our link's price is not the public priceEmbody shows a different price on our link than in public
- The full record, with dates
What one does that the other doesn’t
Trimi
Nothing Embody does not also offer, on the routes we record.
Embody
Offers oral/sublingual where Trimi does not.
Who each one suits
Every line below is a difference we can measure, with the field or criterion it comes from. Where a side is empty, nothing in what we record favours it. We would rather say that than invent a reason.
Trimi
- The two entry figures are not comparable: Embody's rises after the first period.Basis: published price terms (introductory rate)
- Scores clearly higher on transparency (9.0 vs 5.0).Basis: our published scoring rubric
Embody
- Only one of the two offering: oral/sublingual.Basis: published treatments, by drug and route
- Scores clearly higher on treatment (8.0 vs 6.5).Basis: our published scoring rubric
- Its figure is not confirmed. Treat the comparison above as provisional on this side.Basis: price confirmation status